Orthocell LtdASX: OCC

Strongest U.S. Remplir Sales Month Since Launch

· Issued by Orthocell Ltd via ASX

Filed with ASX · · 3 pages · English

Summary by 6ix AI

Orthocell Ltd reports its strongest month of U.S. Remplir sales since launch, achieving significant revenue growth in October. The company sold a notable number of Remplir units, reflecting increased surgeon adoption and broader hospital access. The filing serves as an announcement of commercial performance ahead of the company's upcoming Annual General Meeting.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/strongest-us-remplir-sales-month-since-launch-1

Release

ASX Announcement Orthocell Achieves Strongest Month of U.S. Remplir™ Sales Since Launch October U.S. sales of 92 Remplir units generate AU$279,000 in monthly revenue • Sales of 92 Remplir™ units in October 2026 generated AU$279,000 in revenue, representing an 84% uplift on average monthly...

Orthocell Ltd on 6ix

Earlier from Orthocell

Later from Orthocell

All Orthocell news releases